US Stock MarketDetailed Quotes
CERO CERo Therapeutics
- 0.062
- +0.012+23.37%
Close Dec 24 13:00 ET
- 0.061
- -0.002-2.89%
Post 16:59 ET
9.36MMarket Cap-0.02P/E (TTM)
0.065High0.053Low43.04MVolume0.053Open0.051Pre Close2.53MTurnover64.36%Turnover RatioLossP/E (Static)150.31MShares12.80052wk High-1.30P/B4.17MFloat Cap0.04752wk Low--Dividend TTM66.88MShs Float12.800Historical High--Div YieldTTM24.36%Amplitude0.047Historical Low0.058Avg Price1Lot Size
About CERo Therapeutics Company
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.
Company Profile
SymbolCERO
Company NameCERo Therapeutics
Listing DateNov 30, 2021
Founded2021
CEOMr. Chris Ehrlich
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address201 Haskins Way,Suite 230
CityOakland
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-215-731-9450
Websitehttp://www.cero.bio
Company Executives
- Name
- Position
- Salary
- Chris Ehrlich
- Interim Chairman of the Board and Chief Executive Officer
- --
- Dr. Kristen Pierce, PhD
- Chief Development Officer
- --
- Daniel Corey, M.D.
- Chief Technical Officer and Director
- 376.04K
- Andrew Albert Kucharchuk
- Chief Financial Officer
- --
- Brian G. Atwood
- Director
- --
- Kathleen D. Laporte
- Director
- --
- Michael Byrnes
- Director
- --
- Shami J. Patel
- Director
- --
- Dr. Lindsey Rolfe, M.D.
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data
